AMBER BOCK: Open Payments
NPI 1770822074 · NAMPA, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$720 in 27 payments from 13 companies in 2025. Trend: 2023 $1,077 · 2024 $620 · 2025 $720
Food & beverage: $720
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $106 |
| Boston Scientific Corporation | 1 | $96 |
| Novartis Pharmaceuticals Corporation | 4 | $82 |
| BIOTRONIK INC. | 2 | $78 |
| E.R. Squibb & Sons, L.L.C. | 1 | $61 |
| Actelion Pharmaceuticals US, Inc. | 3 | $57 |
| PFIZER INC. | 2 | $51 |
| Mentor Worldwide LLC | 1 | $41 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $40 |
| ABIOMED | 2 | $37 |
Products named: WATCHMAN, Wegovy, ELIQUIS, LEQVIO, BIOMONITOR, UPTRAVI, MENTOR MemoryGel Resterilizable Gel Sizer, LifeVest.
Industry payments across ID — which companies pay providers there.
